Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Net Margin (2018 - 2026)

TELA Bio has reported Net Margin over the past 8 years, most recently at 145.0% for Q4 2025.

  • For Q4 2025, Net Margin fell 2072.0% year-over-year to 145.0%; the TTM value through Dec 2025 reached 0.59%, down 30.0%, while the annual FY2025 figure was 0.59%, 51.0% down from the prior year.
  • Net Margin for Q4 2025 was 145.0% at TELA Bio, up from 41.58% in the prior quarter.
  • Over five years, Net Margin peaked at 165.72% in Q4 2024 and troughed at 138.81% in Q1 2021.
  • A 5-year average of 61.47% and a median of 80.3% in 2023 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: soared 24587bps in 2024 and later tumbled -2672bps in 2025.
  • Year by year, Net Margin stood at 102.41% in 2021, then increased by 11bps to 91.32% in 2022, then increased by 12bps to 80.14% in 2023, then surged by 307bps to 165.72% in 2024, then dropped by -13bps to 145.0% in 2025.
  • Business Quant data shows Net Margin for TELA at 145.0% in Q4 2025, 41.58% in Q3 2025, and 49.13% in Q2 2025.